Position in ACET
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$273,049
+$199,651 QoQ
Shares Held
31,603
+193.2% QoQ
Ownership
0.338%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 56 holders
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 91%
Shared 3%
None 6%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. ACET ranks #186 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in ACET
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $273,049 | 31,603 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $73,398 | 10,778 | Shares | Sole | 2026-05-07 | |
| 2025-09-30 | $42,899 | 52,963 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,932 | 57,268 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $111,597 | 147,814 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $142,195 | 147,814 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $212,849 | 147,814 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $178,854 | 147,814 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $444,917 | 189,327 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $289,951 | 153,414 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $220,439 | 160,905 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $799,245 | 328,908 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,216,192 | 558,367 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,965,104 | 667,238 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $5,544,747 | 389,926 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,682,223 | 183,714 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,569,901 | 78,613 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $468,312 | 26,776 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $196,415 | 25,053 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $360,139 | 34,999 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||